Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Vet
Pets & Animals/Pet Medications

Stokes Healthcare Inc.: Pilocarpine Ophthalmic Solution Recalled for High Preservative Levels

Agency Publication Date: February 6, 2019
Share:
Sign in to monitor this recall

Summary

Stokes Healthcare Inc. is recalling 85 units of Pilocarpine 0.1% Ophthalmic Solution (10 ML droptainers), a veterinary medication used for eye conditions in animals. The recall was issued because the solution contains a higher concentration of preservative than is typically used in this formulation. This product was distributed to veterinary clinics and pet owners in Alabama, California, Connecticut, Florida, Georgia, Idaho, Michigan, North Carolina, Pennsylvania, Virginia, and Washington.

Risk

Elevated levels of preservatives in eye drops can cause irritation, redness, or discomfort to the animal's eye upon administration. While no injuries have been reported, the excessive preservative level deviates from the intended formula and could potentially cause localized adverse reactions.

What You Should Do

  1. Check the medication container for the product name 'Pilocarpine Ophthn Soln 0.1%' in a 10 ML droptainer.
  2. Verify the identification information on the label: look for Lot Number R180052 and a 'Use By' date of 02/17/2019.
  3. Immediately stop using this medication on your pet if it matches the recalled lot number.
  4. Contact your veterinarian or pharmacist to discuss alternative treatments and to report any adverse reactions your pet may have experienced.
  5. Return any unused portions of the medication to the pharmacy or place of purchase for a refund.
  6. For further information or questions regarding this recall, contact Stokes Healthcare Inc. at 800-754-5222.
  7. For additional assistance, you may contact the FDA's Center for Veterinary Medicine at 240-402-7002.

Your Remedy Options

💰Full Refund

Consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Pilocarpine Ophthn Soln 0.1% (10 ML droptainer)
Lot Numbers:
R180052
Date Ranges: Use By: 02/17/2019

Product Images

Package image, Pilocarpine 0.1% Ophthalmic Solution

Package image, Pilocarpine 0.1% Ophthalmic Solution

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 81794
Status: Resolved
Manufacturer: Stokes Healthcare Inc.
Sold By: veterinary clinics; specialty pharmacies
Manufactured In: United States
Units Affected: 85 droptainers
Distributed To: Alabama, California, Connecticut, Florida, Georgia, Idaho, Michigan, North Carolina, Pennsylvania, Virginia, Washington
Agency Last Updated: April 3, 2019

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response